# Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD

> **NCT03370835** · PHASE4 · COMPLETED · sponsor: **VA Greater Los Angeles Healthcare System** · enrollment: 21 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Asthma
- Adverse Effect of Beta-adrenoreceptor Antagonists

## Interventions

- **DRUG:** Metoprolol succinate ER
- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT03370835
- **Lead sponsor:** VA Greater Los Angeles Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370835, "Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03370835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*